MNKD ▼ -2.9% - MannKind Corporation
$MNKD - MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
09-OCT-2026 08:00 PM ET
Share this post
More filings for $MNKD
MNKD ▲ +2.4% - MannKind CorporationSep 9, 2026MNKD ▼ -1.3% - MannKind CorporationSep 2, 2026$MNKD SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $MNKD filing history →💬 Comments
Loading comments…
Leave a comment